Paper2199202
The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.
Batch J and 6 others. Eur J Clin Pharmacol, 1990. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels. Papers, record 2199202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2199202
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Glucose | Major topic |
| C-Peptide | Major topic |
| Gliclazide | Major topic |
| Insulin | Major topic |
| Sulfonylurea Compounds | Major topic |
| Aged | |
| Diabetes Mellitus, Type 2 | |
| Female | |
| Food | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3882491 | Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects. | Diabetes | 1985 | https://conductscience.org/library/papers/3882491 | PubMed |
| 2 | 345754 | Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. | Acta Med Scand | 1978 | https://conductscience.org/library/papers/345754 | PubMed |
| 3 | 6749526 | The effect of food on the bioavailability and pharmacodynamics of tolbutamide in diabetic patients. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6749526 | PubMed |
| 4 | 7449114 | Observations on comparisons of within-run and day-to-day precision. | Clin Chem | 1981 | https://conductscience.org/library/papers/7449114 | PubMed |
| 5 | 6804245 | Improved effect of glibenclamide on administration before breakfast. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6804245 | PubMed |
| 6 | 6995130 | Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6995130 | PubMed |
| 7 | 6767639 | Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. | Diabetologia | 1980 | https://conductscience.org/library/papers/6767639 | PubMed |
| 8 | 2669710 | The effects of long term gliclazide administration on insulin secretion and insulin sensitivity. | Aust N Z J Med | 1989 | https://conductscience.org/library/papers/2669710 | PubMed |
| 9 | 7002565 | Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7002565 | PubMed |
| 10 | 6488522 | Measurement of gliclazide in plasma by radial compression reversed-phase liquid chromatography. | Clin Chem | 1984 | https://conductscience.org/library/papers/6488522 | PubMed |
| 11 | 3289994 | Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. | Diabetes | 1988 | https://conductscience.org/library/papers/3289994 | PubMed |
| 12 | 6487510 | Improved effect of tolbutamide when given before food in patients on long-term therapy. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6487510 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31758056 | Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model. | Sci Rep | 2019 | https://conductscience.org/library/papers/31758056 | PubMed |
| 10718777 | Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes. | Br J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/10718777 | PubMed |
| 7691511 | Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. | Drugs | 1993 | https://conductscience.org/library/papers/7691511 | PubMed |
| 1623912 | Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1623912 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2199202
GET https://conductscience.org/api/papers/v1/2199202/authors